Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. (DCPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DCPH · as of Jun 9, 2026
Key Statistics
Explore Deciphera Pharmaceuticals, Inc. Data
dcph stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 50.0%
The DCPH analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $26.32, representing +2.85% upside from the current price of $25.59.
Competitors & Peers
dcph competitorsDCPH
CALT
DICE
EMBC
FUSN
KDNYStock Performance
Full HistoryAbout Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical firm focused on developing innovative therapies to significantly improve outcomes for cancer patients. Their core strategy involves tackling the …
what is deciphera pharmaceuticals, inc. · dcph stock overview · deciphera pharmaceuticals, inc. company profile · who is deciphera pharmaceuticals, inc. ceo · dcph NASDAQ · deciphera pharmaceuticals, inc. headquarters · deciphera pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Deciphera Pharmaceuticals, Inc. (DCPH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Sep 28, 2017. As of the latest trading session, DCPH stock price is $25.59, with a market capitalization of $2.2B. The stock has returned +86.92% over the past 12 months and +54.62% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Deciphera Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $26.32. In fiscal year 2023, Deciphera Pharmaceuticals, Inc. reported revenue of $163.4M and net income of -$194.9M. For detailed data — including Deciphera Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Deciphera Pharmaceuticals, Inc. (DCPH) stock price is $25.59. The stock is traded on NASDAQ under the ticker symbol DCPH. The 52-week range is $9.90 – $25.61.